Effects of Botulinum Toxin Injection on Sensation and Postural Control in Children With Hemiplegic Cerebral Palsy

NAUnknownINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

September 30, 2021

Conditions
Cerebral PalsyHemiplegic Cerebral Palsy
Interventions
DRUG

Botulinum toxin type-A (Onabotulinum toxin type-A)

Botulinum toxin-A (Onabotulinum toxin type-A/Botox®) injection will be administered from three different points, two on the medial head of the gastrocnemius muscle and one point on the lateral head with total 3-6 units/kg dose, under the guidance of electrical stimulation for the detection of the target neuromuscular junction.

OTHER

Physical Therapy

After the botulinum toxin-A injection, the patients will be included in the comprehensive physiotherapy program thrice a week for a total of 12 weeks. The physiotherapy program will be consisted of the ankle range of motion and stretching, strengthening of the antagonist muscles, proprioception exercises, functional walking training and static and dynamic balance training.

Trial Locations (1)

Unknown

RECRUITING

Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Marmara University

OTHER

NCT04940143 - Effects of Botulinum Toxin Injection on Sensation and Postural Control in Children With Hemiplegic Cerebral Palsy | Biotech Hunter | Biotech Hunter